Evidence map›Paper›PMID 42039138›Full record

ArticleFrontiers in endocrinology2026

Intact mTOR signaling in gastric X/A-like cells is required for bone homeostasis.

Tiange Feng, Wenzhen Yin, Caroline C Picoli, Linyi Liu, Phuong T Le, Ziyi Liu, Ruili Yu, May Eltahir, Radfar Zohori, Clifford J Rosen and 2 more

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Tiange FengCenter for Molecular Medicine, MaineHealth Institute for Research, Scarborough, ME, United States.
Wenzhen YinClinical Translational Science Center, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing, China.
Caroline C PicoliCenter for Molecular Medicine, MaineHealth Institute for Research, Scarborough, ME, United States.
Linyi LiuCenter for Molecular Medicine, MaineHealth Institute for Research, Scarborough, ME, United States.
Phuong T LeCenter for Molecular Medicine, MaineHealth Institute for Research, Scarborough, ME, United States.
Ziyi LiuUniversity of New England, College of Osteopathic Medicine, Biddeford, ME, United States.
Ruili YuHenan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, China.
May EltahirCenter for Molecular Medicine, MaineHealth Institute for Research, Scarborough, ME, United States.
Radfar ZohoriCenter for Molecular Medicine, MaineHealth Institute for Research, Scarborough, ME, United States.
Clifford J RosenCenter for Molecular Medicine, MaineHealth Institute for Research, Scarborough, ME, United States.
Weizhen ZhangDepartment of Physiology and Pathophysiology, School of Basic Medical Sciences, and Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Peking University, Beijing, China.
Ziru LiCenter for Molecular Medicine, MaineHealth Institute for Research, Scarborough, ME, United States.

Funding

The role of night shift work in metabolic disorders during and after pregnancyP20GM121301 · NIGMS · MAINEHEALTH · PI Elizabeth Scharnetzki · 2017 to 2026
$25.1M
Gastric Endocrine Functions in Skeletal HomeostasisR01DK141613 · NIDDK · MAINEHEALTH · PI LI, ZIRU · 2025 to 2025
$2.6M
NIDDK NIH HHS R01 DK141613NIGMS NIH HHS P20 GM121301
6 · The paper itself

Abstract

Introduction: Beyond its primary digestive functions, the stomach serves as an endocrine organ, secreting peptides that regulate appetite and energy balance. Among its enteroendocrine populations, X/A-like cells play a pivotal role in controlling food intake, glucose homeostasis, and lipid deposition. The secretion of X/A-like cell-derived hormones, including ghrelin and nesfatin-1, is regulated by the mechanistic target of rapamycin (mTOR) signaling pathway. However, the role of X/A-like cell mTOR signaling in skeletal metabolism remains unexplored. Method: Using previously validated and published mouse models with X/A-like cell-specific deletion of Results: Our findings demonstrate that mTOR signaling deficiency in X/A-like cells compromises bone health in male mice, evidenced by cortical bone loss at 12 weeks and trabecular bone reductions at 40 weeks. Furthermore, X/A-like cell-specific Discussion: Collectively, these findings identify a previously unrecognized role of gastric X/A-like cell mTOR signaling in the regulation of bone metabolism. Maintenance of intact mTOR signaling in these endocrine cells is necessary for bone homeostasis, revealing a novel gut-bone endocrine axis.

Indexed as

Bone and BonesEnteroendocrine CellsGastric MucosaHomeostasisSignal TransductionTOR Serine-Threonine KinasesAnimalsFemaleMaleMiceMice, KnockoutOvariectomyTuberous Sclerosis Complex 1 ProteinmTOR protein, mouseTOR Serine-Threonine KinasesTsc1 protein, mouseTuberous Sclerosis Complex 1 ProteinbonemTORstomachTSC1X/A-like cell

Identifiers

PMID42039138
PMCPMC13106587

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.